Real World Data
Real World Data is a Japanese healthcare data technology company that operates Japan's largest EMR-derived medical database (24.4M patients) and sells TidyMed (clinical trial support software) and HYBPMS (hybrid post-marketing survey methodology) to pharmaceutical companies and healthcare institutions.
- Company typePrivate
- Founded2015
- HeadquartersKyoto, Japan
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Real World Data does
Real World Data Co., Ltd. (リアルワールドデータ株式会社) is a Japanese healthcare data technology company founded in 2015 by Kyoto University pharmacoepidemiology faculty and operating as a subsidiary of JMDC Inc. since July 2022. The company builds and operates Japan's largest-scale electronic medical record (EMR)-derived medical database, covering 24.4 million real patients across more than 100 healthcare institutions, and uniquely integrates this with school health checkup and infant health checkup data from 162 municipalities to create a longitudinal life course database. RWD monetizes this data through two core product lines: TidyMed, an on-premises clinical trial support system for hospitals that digitizes paper-based workflows via CTMS, eWorkSheet, and eSource EHR modules integrating directly with hospital EMR systems; and HYBPMS (Hybrid PMS), a post-marketing surveillance methodology that combines DPC, EMR, and receipt data with cloud-based additional data collection, reducing physician data entry burden by approximately 80% versus traditional usage outcome surveys.
The business model spans three revenue streams: enterprise fees from pharmaceutical companies for HYBPMS protocol design, database construction, data collection management, analysis, and publication support; TidyMed service fees paid by pharmaceutical sponsors on behalf of healthcare institutions (which receive the software at no cost); and database access/licensing fees paid by academic institutions, universities, and government/municipalities for epidemiological research and public health planning. RWD operates a sales-led GTM with direct field sales to pharmaceutical companies and direct hospital engagement, augmented by JMDC Group distribution reach (50+ pharma companies, 220+ medical institutions). The company holds ISO/IEC 27001 certification (JQA-IM1377, March 2016) and operates Computerized System Validation (CSV)-compliant on-premises deployments to meet Japanese healthcare data residency and pharmaceutical quality requirements.
RWD's strategic positioning is anchored by a flagship HYBPMS deployment with Eisai (Fycompa, which received PMDA Category 1 re-examination approval in June 2025), a 2025 partnership with Tokushukai Medical Group covering 84 institutions, an Aetion partnership for global RWE platform distribution, and a small but credentialed leadership team of physicians and clinical researchers. Strategic headquarters relocations — culminating in a May 2026 move to Minato-ku, Tokyo — and active hiring for PMS Implementation Lead and Infrastructure Engineer roles signal operational scaling consistent with the company's pipeline expansion.
Real World Data firmographics
Firmographics- Name
- Real World Data
- Legal name
- リアルワールドデータ株式会社 (Real World Data Co., Ltd.)
- Website
- https://rwdata.co.jp
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Real World Data is a Japanese healthcare data technology company that operates Japan's largest EMR-derived medical database (24.4M patients) and sells TidyMed (clinical trial support software) and HYBPMS (hybrid post-marketing survey methodology) to pharmaceutical companies and healthcare institutions.
- Ownership category
- akta.pro rank
Real World Data industry classification
Industry- Product category
- Healthcare Real-World Evidence and Clinical Trial Software
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370), Services-Health Services (8000)
- akta.pro primary industry
- Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ)
- akta.pro secondary industries
- De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK), Record Locator Services (RLS) & Longitudinal Record Aggregation (HLACABAH), Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm) (HLACAIAF), Healthcare Utilization, Claims & Administrative Data Analytics (HLAJAJAK)
Keywords
Where Real World Data is headquartered
LocationHeadquarters
- HQ city
- Kyoto
- HQ country
- Japan
- HQ region
- Asia
Offices2 records
Markets served
Real World Data business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Database Utilization Services: RWD collects, anonymizes, and provides medical/health information databases (electronic medical records, DPC data, receipt data) to academic institutions, pharmaceutical companies, and researchers. Revenue is generated through database access fees, data provision fees, and research project collaborations. The company supports HCEI (Health, Medical, and Educational Information Evaluation Organization) in database administration, data utilization review committee operations, and system standardization.
- HYBPMS Post-Marketing Survey Services: RWD provides HYBPMS services to pharmaceutical companies, conducting hybrid post-marketing database surveys that combine existing medical data with additional prospective data collection. Revenue is generated through project-based fees for survey design, protocol creation, database construction, data collection management, analysis, and publication support. RWD also earns referral fees by introducing PMS projects to healthcare institutions.
- TidyMed Clinical Trial Support Software: TidyMed is provided to healthcare institutions (clinical research centers, trial management offices) as an on-premises electronic medical record department system. RWD appears to provide this to healthcare institutions, with costs covered by pharmaceutical companies or as part of service agreements. The system enables clinical trial workflow digitalization, generating revenue through deployment and ongoing support.
- Collaborative Research and Analysis: RWD conducts joint research projects with healthcare institutions and pharmaceutical companies, providing data analysis, epidemiological research support, and publication services. Revenue is generated through research collaboration agreements, data analysis contracts, and consulting fees.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | TidyMed is provided to healthcare institutions at no cost, with pharmaceutical companies bearing the service fees as part of clinical trial support arrangements. |
| Outcome Based/ Performance | Multi-year contract | HYBPMS is offered at reduced total cost compared to traditional post-marketing surveys, with savings in monitoring management and operational costs for pharmaceutical companies. |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Real World Data product offering
Product offeringCore offering
Real World Data Co., Ltd. operates one of Japan's largest-scale electronic medical record-derived medical information databases, covering over 24.4 million real patients from 100+ healthcare institutions, and sells two core products: TidyMed®, a clinical trial support application for hospitals that digitizes workflows (eWorksheets, eSource EHR integration, CTMS, electronic signatures); and HYBPMS®, a hybrid post-marketing database survey service combining existing DPC, EMR, and receipt data with prospective cloud-based collection to reduce physician data entry burden by approximately 80% versus traditional usage outcome surveys.
Product overview
Real World Data Co., Ltd. operates as a healthcare data technology company with two primary business segments: Medical Institution Support Services and Clinical Development/PMS Support Services. The company's core product portfolio centers on TidyMed® (electronic medical record-integrated clinical trial support system) and HYBPMS® (additional data collection-type post-marketing database survey), supported by a large-scale electronic medical record-derived database. TidyMed provides a suite of clinical trial support modules including eWorkSheet, eSource EHR, and CTMS; HYBPMS provides post-marketing survey services combining DPC/EMR data with supplementary data collection. The products work together to address clinical trial efficiency and post-marketing survey burden reduction for medical institutions and pharmaceutical companies.
Differentiator
Problem solved
Functional benefit
Products and services
- TidyMed® Clinical trial and clinical research support application for medical institutions that integrates with electronic medical record systems. Provides eWorkSheet, eSource EHR integration, CTMS, patient screening, electronic signatures, and EDC data import functionality to digitize paper-based clinical trial workflows and reduce data entry burden on medical staff.
- HYBPMS® Additional data collection-type post-marketing database survey service combining DPC data, electronic medical record data, and receipt data with cloud-based supplementary data collection. Reduces physician data entry workload by approximately 80% by leveraging existing medical data for medical history, comorbidities, and concomitant medications, collecting only outcomes and adverse event data not present in existing databases.
- RWD Database (Electronic Medical Record-Derived Database)
Quantifiable outcome
- HYBPMS reduces physician data entry burden by approximately 80% compared to traditional usage outcome surveys, according to RWD's own research
- +2 more outcomes
Companies that use Real World Data
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Real World Data technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature5 records
Real World Data partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered flagship and core.
- Tokushukai Medical Group (徳洲会)flagshipBusiness partnership for conducting HYBPMS post-marketing database surveys across the Tokushukai medical group. The partnership enables rapid expansion to 84 Tokushukai facilities (77 with EMR, 51 DPC facilities), providing broad geographic coverage for HYBPMS surveys. Tokushukai is Japan's largest medical group, making this partnership critical for scaling HYBPMS nationwide.
- Tokushukai Information System (徳洲会インフォメーションシステム/TIS)flagshipTIS provides centralized data management for Tokushukai's electronic medical record systems. Through the partnership, RWD gains access to reliably managed data from Tokushukai facilities, enabling consistent HYBPMS operations across the medical group's 84 institutions.
- Kurashiki Central Hospital (倉敷中央病院)flagshipJoint research partnership between Kurashiki Central Hospital and JMDC Group to use electronic medical record databases for generating evidence supporting pediatric off-label drug public knowledge applications (公知申請). As part of JMDC's 'Big Data For Children' project, the collaboration aims to generate evidence for Plaquenil (プラケニル) pediatric use in Japan. Kurashiki Central Hospital is also the first to deploy TidyMed with eWorkSheet and eSource EHR features.
- Eisai Co., Ltd. (エーザイ株式会社)flagshipEisai collaborated with RWD on Japan's first additional data collection-type post-marketing database survey (HYBPMS) for Fycompa (フィコンパ). This pioneering HYBPMS methodology combined existing electronic medical record, receipt, and DPC data with prospective additional data collection, enabling a post-marketing survey that would not have been possible with traditional methods. Eisai's Fycompa subsequently received PMDA Category 1 re-examination approval in June 2025, validating the HYBPMS approach.
- JMDC (株式会社JMDC)coreJMDC acquired shares in RWD, making it a JMDC group subsidiary. This capital and business partnership enables RWD to leverage JMDC's established network of 50+ pharmaceutical companies and 220+ medical institutions/academia. JMDC is a healthcare big data pioneer with 1.25 billion+ receipt records and 62 million+ health checkup records. The partnership combines RWD's electronic medical record database (24.4 million patients) with JMDC's data assets and market reach.
- Aetion, Inc. (エイティオン)flagshipFirst-in-Japan partnership for joint promotion of real-world evidence services. Aetion provides a global real-world evidence platform used in international clinical development. RWD provides its electronic medical record database (24.4 million patients as of March 2022) for use on Aetion's platform, enabling Japanese healthcare data to contribute to global drug development. RWD and Aetion jointly respond to pharmaceutical company requests for RWD data utilization on the Aetion platform.
Scale indicators9 records
Recent moves8 records
Expansion highlights5 records
Real World Data competitors and assessment
Company assessmentDirect peers
- Flatiron Health: Oncology-focused real-world data company aggregating EMR data for cancer research, drug development, and post-marketing studies, serving pharma and regulators. Directly comparable to RWD's RWD platform and post-marketing surveillance offering, specialized by therapeutic area.
- Medical Data Vision Co., Ltd. Japan-focused healthcare data company specializing in DPC and EMR-derived real-world databases, serving pharma companies for post-marketing surveillance, clinical research, and academic studies. Direct peer to RWD with overlapping Japan RWD/PMS use cases, similar customer base, and competing data assets.
- Medidata Solutions (Dassault Systèmes): Industry-leading clinical trial technology platform providing EDC, eCOA, CTMS, and eSource solutions for pharma-sponsored and investigator-initiated trials. Directly comparable to RWD's TidyMed clinical trial support system and eSource EHR integration functionality.
- Aetion, Inc. RWE analytics platform used by pharma and regulators to evaluate real-world data for drug effectiveness and safety decisions; RWD is a First-in-Japan data partner. Highly comparable in RWE service offering, methodology, and pharmaceutical customer base.
- TriNetX, Inc. Global real-world data and evidence platform connecting healthcare organizations and pharma for clinical trial feasibility, cohort discovery, and RWE generation. Directly comparable to RWD's database and post-marketing surveillance business model, scaled to a global network.
Emerging players
- Clinerion Ltd. International real-world data and patient identification platform connecting hospital EMRs to pharma for clinical trial feasibility and RWE. Comparable to RWD's hospital-network-based RWD and clinical trial support business but at earlier stage and focused on emerging markets.
Broad incumbents
- IQVIA Holdings Inc. Global leader in clinical research services, real-world evidence, and healthcare data analytics serving pharmaceutical companies across the full drug development lifecycle. Comparable to RWD in PMS and clinical trial data services but with a much broader portfolio and global scale.
- JMDC Inc. Parent company of RWD and Japan's largest claims-and-checkup healthcare data company (1.25B+ receipt records, 62M+ health checkup records). Highly comparable in that it operates the same Japan-centric RWD/data platform business, and is RWD's direct upstream data and distribution parent, making it the closest reference point for RWD's market position.
- Health Catalyst, Inc. Healthcare data and analytics platform providing data warehousing, quality measurement, and population health analytics to health systems and life sciences companies. Comparable to RWD in EMR-derived data infrastructure and hospital customer base, though more focused on US provider analytics.
- M3, Inc. Japan-headquartered global healthcare platform operating MR-kun, clinical trial services, and medical data businesses, including drug database and physician network services. Comparable to RWD in serving Japanese pharma with data-driven clinical development and post-marketing offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Real World Data social profiles
Digital presenceReal World Data compliance and trust
Trust signalCompliance3 records
Real World Data financial estimates
Financial estimateRevenue estimate
Valuation estimate
Real World Data leadership team
Management profileNumber of profiles
Profiles1 record
Real World Data funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Real World Data M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Real World Data
What does Real World Data do?
Real World Data Co., Ltd. operates one of Japan's largest-scale electronic medical record-derived medical information databases, covering over 24.4 million real patients from 100+ healthcare institutions, and sells two core products: TidyMed®, a clinical trial support application for hospitals that digitizes workflows (eWorksheets, eSource EHR integration, CTMS, electronic signatures); and HYBPMS®, a hybrid post-marketing database survey service combining existing DPC, EMR, and receipt data with prospective cloud-based collection to reduce physician data entry burden by approximately 80% versus traditional usage outcome surveys.
Is Real World Data a public or private company?
Real World Data is a private company. It is classified as corporate owned and is currently operating.
When was Real World Data founded?
Real World Data was founded in 2015. It employs 1 to 10 people.
Where is Real World Data based?
Real World Data is headquartered in Kyoto, Japan, in the Asia region.
How does Real World Data make money?
Four revenue lines are on record. Medical Database Utilization Services are the primary driver. The others are HYBPMS Post-Marketing Survey Services, tidyMed Clinical Trial Support Software and collaborative Research and Analysis.
Who are Real World Data's main competitors?
Direct peers on record are Flatiron Health, Medical Data Vision Co., Ltd., Medidata Solutions (Dassault Systèmes), Aetion, Inc. and TriNetX, Inc.. Clinerion Ltd. is listed as an emerging player. Broad incumbents are IQVIA Holdings Inc., JMDC Inc., Health Catalyst, Inc. and M3, Inc..
Does Real World Data have an API?
No public API is recorded for Real World Data.
What industry is Real World Data in?
Real World Data's product category is Healthcare Real-World Evidence and Clinical Trial Software. Its primary akta.pro industry code is HLACAIAJ, Real-World Data (RWD) Platforms & Clinical Data Curation, with a secondary code of HLACAIAK, De-identification, Tokenization & Privacy-Preserving Data Platforms. Its NAICS code is 518210 and its SIC code is 7370.